Montironi R.; Gasparrini S.; Cimadamore A.; Mazzucchelli R.; Massari F.; Cheng L.; Lopez-Beltran A.; Briganti A.; Scarpelli M., Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View, «EUROPEAN UROLOGY. SUPPLEMENTS», 2017, 16, pp. 223 - 231 [articolo]
Santini D.; Ratta R.; Pantano F.; De Lisi D.; Maruzzo M.; Galli L.; Biasco E.; Farnesi A.; Buti S.; Sternberg C.N.; Cerbone L.; Di Lorenzo G.; Spoto S.; Sterpi M.; De Giorgi U.; Berardi R.; Torniai M.; Camerini A.; Massari F.; Procopio G.; Tonini G., Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis, «ONCOTARGET», 2017, 8, pp. 100708 - 100716 [articolo]Open Access
Inno A.; Metro G.; Bironzo P.; Grimaldi A.M.; Grego E.; Nunno V.D.; Picasso V.; Massari F.; Gori S., Pathogenesis, clinical manifestations and management of immune checkpoint inhibitors toxicity, «TUMORI», 2017, 103, pp. 405 - 421 [articolo]
Gasparrini S.; Cimadamore A.; Mazzucchelli R.; Scarpelli M.; Massari F.; Raspollini M.R.; Galosi A.B.; Lopez-Beltran A.; Cheng L.; Montironi R., Pathology and molecular updates in tumors of the prostate: towards a personalized approach, «EXPERT REVIEW OF MOLECULAR DIAGNOSTICS», 2017, 17, pp. 781 - 789 [articolo]
Vau N.; Volavsek M.; Blanca A.; Montironi R.; Raspollini M.R.; Massari F.; Cheng M.; Scarpelli M.; Lopez-Beltran A., Prospects for precision therapy of bladder urothelial carcinoma, «EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT», 2017, 2, pp. 261 - 274 [articolo]
Gasparrini S.; Mazzucchelli R.; Scarpelli M.; Massari F.; Raspollini M.R.; Lopez-Beltran A.; Cheng L.; Montironi R., Prostate cancer grading in 2016, «MINERVA UROLOGICA E NEFROLOGICA», 2017, 69, pp. 1 - 4 [articolo]
Ciccarese, Chiara; Massari, Francesco; Iacovelli, Roberto; Fiorentino, Michelangelo; Montironi, Rodolfo; Di Nunno, Vincenzo; Giunchi, Francesca; Brunelli, Matteo; Tortora, Giampaolo, Prostate cancer heterogeneity: Discovering novel molecular targets for therapy, «CANCER TREATMENT REVIEWS», 2017, 54, pp. 68 - 73 [articolo]
Petrylak D.P.; de Wit R.; Chi K.N.; Drakaki A.; Sternberg C.N.; Nishiyama H.; Castellano D.; Hussain S.; Flechon A.; Bamias A.; Yu E.Y.; van der Heijden M.S.; Matsubara N.; Alekseev B.; Necchi A.; Geczi L.; Ou Y.-C.; Coskun H.S.; Su W.-P.; Hegemann M.; Percent I.J.; Lee J.-L.; Tucci M.; Semenov A.; Laestadius F.; Peer A.; Tortora G.; Safina S.; del Muro X.G.; Rodriguez-Vida A.; Cicin I.; Harputluoglu H.; Widau R.C.; Liepa A.M.; Walgren R.A.; Hamid O.; Zimmermann A.H.; Bell-McGuinn K.M.; Powles T.; Wong S.-L.S.; Tan T.H.; Hovey E.J.; Clay T.D.; Ng S.S.W.; Rutten A.; Machiels J.-P.; Dumez H.; Cheng S.Y.-S.; Ferrario C.; Sengeloev L.; Jensen N.V.; Thibault C.; Laguerre B.; Joly F.; Flechon A.; Culine S.; Becht C.; Niegisch G.; Stockle M.; Grimm M.-O.; Gakis G.; Schultze-Seemann W.; Kalofonos H.; Mavroudis D.; Papandreou C.; Karavasilis V.; Revesz J.; Geczi L.; Rosenbaum E.; Leibowitz-Amit R.; Kejzman D.; Sarid D.; Scagliotti G.V.; Bracarda S.; Massari F.; Osawa T.; Miyajima N.; Shinohara, Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial, «THE LANCET», 2017, 390, pp. 2266 - 2277 [articolo]
Montironi R.; Gasparrini S.; Mazzucchelli R.; Massari F.; Cheng L.; Lopez-Beltran A.; Montorsi F.; Scarpelli M., Re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738–9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides, «EUROPEAN UROLOGY», 2017, 71, pp. 73 - 75 [articolo]
Montironi R.; Lopez-Beltran A.; Cheng L.; Gasparrini S.; Montironi M.A.; Massari F.; Scarpelli M.; Montorsi F., Re: Kenneth A. Iczkowski's Letter to the Editor re: Re: Rodolfo Montironi, Silvia Gasparrini, Roberta Mazzucchelli, et al's Letter to the Editor re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738–9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides. Eur Urol 2017;71:e73–5, «EUROPEAN UROLOGY», 2017, 72, pp. 37 - 38 [articolo]
Massari F, Di Nunno V, Ardizzoni A, Re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.09.008, «EUROPEAN UROLOGY», 2017, 8, pp. 72 - 73 [articolo]
Montironi R.; Gasparrini S.; Lopez-Beltran A.; Cheng L.; Massari F.; Montorsi F.; Scarpelli M., Re: Umberto Leone Roberti Maggiore, Simone Ferrero, Massimo Candiani, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017;71:790–807, «EUROPEAN UROLOGY», 2017, 72, pp. 139 - 141 [articolo]
Massari F.; Ciccarese C.; Bria E.; Porta C.; La Russa F.; Knuutila S.; Artibani W.; Porcaro A.B.; Bimbatti D.; Modena A.; Sava T.; Tortora G.; Cheng L.; Eccher A.; Cima L.; Pedron S.; Ghimenton C.; Martignoni G.; Brunelli M., Reprofiling metastatic samples for chromosome 9p and 14q aberrations as a strategy to overcome tumor heterogeneity in clear-cell renal cell carcinoma, «APPLIED IMMUNOHISTOCHEMISTRY AND MOLECULAR MORPHOLOGY», 2017, 25, pp. 39 - 43 [articolo]
Montironi, Rodolfo; Cheng, Liang; Moch, Holger; Lopez-Beltran, Antonio; Scarpelli, Marina; Massari, Francesco; Fiorentino, Michelangelo; Ciccarese, Chiara; Koch, Michael; Kaimakliotis, Hristos Z; Wang, Lisha; Pili, Roberto; Mann, Steven A, Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives, «CURRENT DRUG METABOLISM», 2017, 18, pp. 0 - 0 [articolo]
Ciccarese C.; Iacovelli R.; Bria E.; Modena A.; Massari F.; Brunelli M.; Fantinel E.; Bimbatti D.; Zamboni G.A.; Artibani W.; Tortora G., The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: A meta-analysis of current studies, «IMMUNOTHERAPY», 2017, 9, pp. 579 - 587 [articolo]
